Cargando…

Efficacy and safety of maintenance electroconvulsive therapy for sustaining resolution of severe aggression in a major neurocognitive disorder

We report a novel electroconvulsive therapy (ECT) regimen for sustaining the resolution of behavioural and psychological symptoms of dementia (BPSD) using alternating acute and maintenance ECT (M-ECT) trials. A 64-year-old man presenting with major neurocognitive disorder was admitted for acute beha...

Descripción completa

Detalles Bibliográficos
Autores principales: Selvadurai, Melanie Isabella, Waxman, Robyn, Ghaffar, Omar, Fischler, Ilan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5775786/
https://www.ncbi.nlm.nih.gov/pubmed/29305363
http://dx.doi.org/10.1136/bcr-2017-222100
_version_ 1783293979305967616
author Selvadurai, Melanie Isabella
Waxman, Robyn
Ghaffar, Omar
Fischler, Ilan
author_facet Selvadurai, Melanie Isabella
Waxman, Robyn
Ghaffar, Omar
Fischler, Ilan
author_sort Selvadurai, Melanie Isabella
collection PubMed
description We report a novel electroconvulsive therapy (ECT) regimen for sustaining the resolution of behavioural and psychological symptoms of dementia (BPSD) using alternating acute and maintenance ECT (M-ECT) trials. A 64-year-old man presenting with major neurocognitive disorder was admitted for acute behavioural disturbances and physical aggression. With few treatment options, the impact on patients’ quality of life often supersedes cognitive symptoms and is a predictor of long-term institutionalisation. Recent studies indicate that ECT may be an effective and safe way to address BPSD. Clinicians have little information about when and how to stop a successful course of acute ECT or the long-term advantages of M-ECT with subsequent intermittent acute ECT. This case emphasises the benefit of M-ECT and describes potential challenges associated with abrupt discontinuation. This case is the first to detail tapering ECT for treatment of aggression in dementia by interchanging acute and M-ECT courses in response to symptom burden.
format Online
Article
Text
id pubmed-5775786
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-57757862018-01-29 Efficacy and safety of maintenance electroconvulsive therapy for sustaining resolution of severe aggression in a major neurocognitive disorder Selvadurai, Melanie Isabella Waxman, Robyn Ghaffar, Omar Fischler, Ilan BMJ Case Rep Novel Treatment (New Drug/Intervention; Established Drug/Procedure in New Situation) We report a novel electroconvulsive therapy (ECT) regimen for sustaining the resolution of behavioural and psychological symptoms of dementia (BPSD) using alternating acute and maintenance ECT (M-ECT) trials. A 64-year-old man presenting with major neurocognitive disorder was admitted for acute behavioural disturbances and physical aggression. With few treatment options, the impact on patients’ quality of life often supersedes cognitive symptoms and is a predictor of long-term institutionalisation. Recent studies indicate that ECT may be an effective and safe way to address BPSD. Clinicians have little information about when and how to stop a successful course of acute ECT or the long-term advantages of M-ECT with subsequent intermittent acute ECT. This case emphasises the benefit of M-ECT and describes potential challenges associated with abrupt discontinuation. This case is the first to detail tapering ECT for treatment of aggression in dementia by interchanging acute and M-ECT courses in response to symptom burden. BMJ Publishing Group 2018-01-05 /pmc/articles/PMC5775786/ /pubmed/29305363 http://dx.doi.org/10.1136/bcr-2017-222100 Text en © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Novel Treatment (New Drug/Intervention; Established Drug/Procedure in New Situation)
Selvadurai, Melanie Isabella
Waxman, Robyn
Ghaffar, Omar
Fischler, Ilan
Efficacy and safety of maintenance electroconvulsive therapy for sustaining resolution of severe aggression in a major neurocognitive disorder
title Efficacy and safety of maintenance electroconvulsive therapy for sustaining resolution of severe aggression in a major neurocognitive disorder
title_full Efficacy and safety of maintenance electroconvulsive therapy for sustaining resolution of severe aggression in a major neurocognitive disorder
title_fullStr Efficacy and safety of maintenance electroconvulsive therapy for sustaining resolution of severe aggression in a major neurocognitive disorder
title_full_unstemmed Efficacy and safety of maintenance electroconvulsive therapy for sustaining resolution of severe aggression in a major neurocognitive disorder
title_short Efficacy and safety of maintenance electroconvulsive therapy for sustaining resolution of severe aggression in a major neurocognitive disorder
title_sort efficacy and safety of maintenance electroconvulsive therapy for sustaining resolution of severe aggression in a major neurocognitive disorder
topic Novel Treatment (New Drug/Intervention; Established Drug/Procedure in New Situation)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5775786/
https://www.ncbi.nlm.nih.gov/pubmed/29305363
http://dx.doi.org/10.1136/bcr-2017-222100
work_keys_str_mv AT selvaduraimelanieisabella efficacyandsafetyofmaintenanceelectroconvulsivetherapyforsustainingresolutionofsevereaggressioninamajorneurocognitivedisorder
AT waxmanrobyn efficacyandsafetyofmaintenanceelectroconvulsivetherapyforsustainingresolutionofsevereaggressioninamajorneurocognitivedisorder
AT ghaffaromar efficacyandsafetyofmaintenanceelectroconvulsivetherapyforsustainingresolutionofsevereaggressioninamajorneurocognitivedisorder
AT fischlerilan efficacyandsafetyofmaintenanceelectroconvulsivetherapyforsustainingresolutionofsevereaggressioninamajorneurocognitivedisorder